I wouldn't say it's being pumped. Lenzulimab has a decent chance of making stat sig with full enrollment. There will be a better drug out there but both will be needed for the COVID-19 fight.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.